Mesoblast Limited vs PAGSEG Inc — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while PAGSEG Inc trades at $9.61 (market cap $2.60B). The key difference: PAGSEG Inc is the larger of the two by market cap, and PAGSEG Inc pays a 11.19% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | PAGS | |
|---|---|---|
Market Cap | $2.17B | $2.60B |
Sector | Technology | Technology |
52-Week High | $20.96 | $12.00 |
52-Week Low | $12.88 | $7.75 |
Enterprise Value | $2.17B | $10.23B |
Dividend Yield | — | 11.19% |
Trailing returns across standard periods
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →